PHP25 EXPENDITURES ON DRUGS IN DEVELOPED EUROPEAN COUNTRIES

Tourism Impact on Air Pollution in Developed and Developing Countries

T he main purpose of this paper is to investigate and compare the impact of tourism on air pollution in selected developed and developing countries during the period of 1995-2014. To this end, at first, the model was designed based on the Environmental Kuznets Curve (EKC) assumptions and with the presence of the major influencing factors on air pollution along with the international ...

Treatment Costs for Pediatrics Acute Lymphoblastic Leukemia; Comparing Clinical Expenditures in Developed and Developing Countries: a Review Article

Background                                               Pediatric acute lymphoblastic leukemia (ALL) is the most common, yet curable childhood malignancy within the pediatric cancers; but in most developed and developing countries cost of cancer treatment in children with ALL is high. So, we specified the range of expenses for the treatment of pediatric cancer and compared the results in devel...

Health Expenditures in Developing Countries: Determinants and Guidelines

Background: In this paper, the health expenditures function of developing countries is estimated with a panel data model.  Methods: All credible determinants of health expenditures in these countries are probed and their coefficients are found out. Variables that affect health expenditures in developing countries are income, demographic features, social characteristics, and technological progr...

Impact of R&D expenditures on research publications, patents and high-tech exports among European countries.

OBJECTIVES This study aimed to compare the impact of Research&Development (R&D) expenditures on research publications, patents and high-tech exports among European countries. MATERIALS AND METHODS In this study, 47 European countries were included. The information regarding European countries, their per capita Gross Domestic Product (GDP), R&D spending, number of universities, indexed scienti...

Actual costs of cancer drugs in 15 European countries.